MorphoSys drops after capital increase
** Shares in MorphoSys MORG.DE slump almost 14% in
pre-market trade after the German biotech firm launched a 10%
cash capital increase
** Shares were placed at 30 euros, resulting in gross
proceeds of about 102.7 million euros
** The stock is at the bottom of the German small-caps index
.SDAXI
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))
Recent news on Morphosys AG
See all newsBrief: Morphosys Announces Voluntary Delisting From The Nasdaq Global Market
Brief: Morphosys Says Merger Squeeze-Out Cash Compensation Determined At Eur 68.00
Brief: Morphosys And Novartis Sign Delisting Agreement
Brief: Novartis BidCo Germany plans merger squeeze-out of Morphosys minority shareholders
Brief: Morphosys: Pichota and Lukas Gilgen replacing CEO And CFO